Mizoram News Pulse
Buisness

The Q4 PAT reported by Torrent Pharma was 287 crore rupees

On the strength of strong sales across regions, Torrent Pharma on Tuesday declared a consolidated profit after tax of Rs 287 crore for the fourth quarter ended March 2023.

In the January-March quarter of the 2021–22 fiscal year, the medicine manufacturer had recorded a net loss of Rs 118 crore.

According to a statement from Torrent Pharma, the company's sales increased to Rs 2,491 crore for the fourth quarter from Rs 2,131 crore in the same quarter last year.

The medicine manufacturer reported a profit after tax of Rs 1,245 crore for the year that ended March 2023 as opposed to Rs 777 crore in FY22.

Last fiscal year, the income increased to Rs 9,620 crore from Rs 8,508 crore.

According to the business, the board of directors advised the shareholders to approve the issuing of shares, convertible bonds, and debentures via qualified institutional placement (QIP), depository receipts, or any other means for a sum not to exceed Rs 5,000 crore.

A final dividend of Rs 8 per share of Rs 5 was also authorised by the board.

On the BSE, shares of the pharmaceutical company finished 0.69 percent higher at Rs 1,717.15.

Related posts

Apple Watch 2024 Will Include Sleep Apnea Detection And Blood Pressure Monitoring

Beginning in September, a new program will provide interest rate relief on home loans

Top Selling Vehicles These are the vehicles that are selling the best in India this year; they are well-established in their respective markets

The cryptocurrency market remains volatile as it struggles with economic indicators and investor sentiment

Elon Musk Wants To Purchase The iPhone 15 Because

After posting 56% listing gains, IREDA shares make their stellar market debut. Should you buy, sell, or hold?